Company Summary

Proxy Biomedical Limited was set up on Friday the 10th of May 2002. Their current address is Co. Galway, and the company status is Normal. The company's current directors Bernard Collins, Peter Gingras, Peter Mulrooney and Michael Kinsella have been the director of 57 other Irish companies between them; 16 of which are now closed. Proxy Biomedical Limited has 1 shareholder.

Company Name:Proxy Biomedical Limited
Company Status:NORMAL
Company Address:Colleach,
Baile an TslÊibhe,
Spiddal,
Co. Galway
Telephone:+353 (0)91 896 900
Website:www.proxybiomedical.com
Key Executive:Peter Gingras
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Peter Gingras is a Company Director of Proxy Biomedical Limited since 2002 and a listed Director of 6 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Proxy Biomedical Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
B1 ANNUAL RETURN30/09/201727/09/2017Join Up
ACCOUNT DETAILS31/12/201627/09/2017Join Up
OTHER DIRECTORSHIP LIST30/09/201727/09/2017Join Up
C6 MEMO OF SATISFACTION OF A CHARGE-FULL31/12/201629/05/2017Join Up
B5 RETURN OF ALLOTMENTS.27/03/201720/04/2017Join Up
THIS COMPANY HAS 119 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Proxy Biomedical Limited.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:25/10/2017
Latest Accounts Filed:27/09/2017
Report Based on Accounts:31/12/2016
Next Set of Accounts Due:30/09/2018
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Proxy Biomedical Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors

Satisfy due diligence requirments on Proxy Biomedical Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Proxy Biomedical Limited and Anti-Money Laundering checks (AML checks) on Proxy Biomedical Limited

Director:Bernard Collins
Director:Michael Kinsella
Other Directors:Proxy Biomedical Limited has 2 other Directors.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Proxy Biomedical Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

2 out of 3 businesses say their costs are higher today than pre-recession levels

23/10/2017

2 out of 3 businesses say their costs are higher today than pre-recession levels. The Vision-net 'Cost Of Doing Business Report', highlights the increasing trend towards rising business costs.

Read More »

A Brexit business plan could be the difference between boom and bust

23/10/2017

Companies worried by rising costs of doing business in Ireland

Read More »

133m in judgment awards between January & August '17 for failure to repay debt

12/09/2017

An overview of the key bad debt judgment awards made against companies and consumers between January and August 2017

Read More »

An average of 1,900 start-ups formed monthly in the first half of 2017

17/07/2017

A breakdown of the key trends affecting Irish companies between January and June 2017

Read More »